Connect with us

CBG

How Rapid Relief Cooling Gel with CBG, CBD & THC nails the recipe for relief

Published

on


Rare Cannabinoid Company’s newest product is a secret weapon against soreness. Try a free sample today. Plus, enjoy nearly 30% off with special introductory & subscription offers this month.


The plant-power mavens behind the highest-strength THCV gummies on the market today are back with their newest innovative remedy: Rapid Relief Cooling Gel combining hemp-based CBG, CBD, and delta-9 THC.

Rare Cannabinoid Company shared samples of their brand new topical lotion with our team, and they couldn’t have arrived at a better time—as someone who just completed a grueling move while simultaneously re-starting a jogging routine, relief has been top-of-mind.

We tried Rare Cannabinoid Company’s CBG+CBD+THC Rapid Relief Cooling Gel, and the best way for you to understand the benefits of this high-powered topical is to do the same:

The brand is offering completely free samples of their new product, shipping included. All you need to do is provide your shipping information to receive a free packet of RCC’s Rapid Relief Cooling Gel in the mail.

So, what’s the secret behind this special relief formula? Rare Cannabinoid Company’s signature is in unlocking the best combination of cannabinoids to target specific needs and including them in higher potency amounts than you’re likely to find anywhere else.

With 1000mg CBG oil, 1000mg CBD oil, and 400mg delta-9 THC in every bottle, the Rapid Relief Cooling Gel is yet another standard-setting winner from the brand’s apothecary suite. It packs in more pain & inflammation-busting THC than you’ll find anywhere outside of a licensed dispensary—and even in one for a topical application, with most dispensary products tapping out at around 100mg THC for similar-sized bottles—with a Farm Bill-compliant, hemp-based formula that ships nationally.

CBD is well-studied for its potential joint relief and muscle recovery properties, and CBG is the lesser-known clincher of the crew, with studies suggesting it may have even more pain-relieving properties than THC.

But as the entourage effect theory in cannabis instructs, the real magic lies in the combination of these three plant compounds. RCC decided on this particular cannabinoid ratio based on research that suggests that THC+CBD+CBG combined “was more effective than these compounds applied alone,” for addressing chronic pain.

Not your average topical

Rapid Relief Cooling Gel
Courtesy of Rare Cannabinoid Company

Rare Cannabinoid Company designed their new CBD cream with the best trio of cannabinoids to relieve discomfort and support healthy joints. But CBG, CBD, and D-9 THC aren’t the only hard-working ingredients under the hood—you’ll also find Arnica, Menthol, Dandelion, Horsetail, Gotu Kola, and even more—all hand-picked to add extra oomph to the lotion’s pain-relieving properties.

If you’re like me, though, even the best relief formula will sit on the shelf if it’s heavy, sticky, or overly scented. Thankfully, RCC’s weightless formula is none of these. In fact, the cream goes on smooth with a welcome cooling effect and comforting light-mint aroma and absorbs completely on the skin within just a few minutes. The effect is akin to a luxury massage lotion, like a quick trip to the spa right at home.

You apply the cooling gel topically directly to the affected area so the gel can go to work right where it counts. Despite its hefty milligram amount of D-9 THC, the gel does not have any psychoactive effects, so you can use it any time of day for rapid relief. Ideal for stiff joints, sore muscles, and post-exercise recovery, the gel is equally at home with old-bones havers and elite athletes.

Why CBG, CBD, and D-9 THC?

Let’s take a closer look at why Rare Cannabinoid Company selected the combination of CBG, CBD, and THC to power their Rapid Relief Cooling Gel.

Delta-9 THC, the primary cannabinoid found in cannabis and hemp plants, is also one of the most studied for its pain-relieving effects. This medical review of multiple studies that found that “THC has twenty times the anti-inflammatory potency of aspirin and twice that of hydrocortisone” is a prime example of the work being done to show how THC interacts positively with pain and discomfort.

CBD oil also has its own unique relationship to inflammation and pain management. In one animal study, topical CBD was found to be effective for arthritis pain and inflammation. And in a human trial focused on former professional athletes living with chronic pain, the study found that after six weeks of CBD treatment, the group reported decreased pain and improved function.

Rapid Relief Cooling Gel
Courtesy of Rare Cannabinoid Company

CBG has long been on Rare Cannabinoid Company and other cutting-edge companies’ radars as potentially having even more significant pain-relieving properties than the obvious powerhouse, THC. This study found that “CBG has more potent analgesic (pain-relieving), anti-erythema (anti-inflammatory rash) and lipoxygenase (inflammation) blocking activity than THC,” while another found that the compound may work by blocking the transmission of pain signals.

Related

Is CBG better than CBD and THC for pain, inflammation, and aging?

Taken together, each of these cannabinoid’s individual properties combine to produce something altogether different. This chronic pain study highlights the potential of using the specific three-cannabinoid combination of CBG+CBD+THC, finding that “THC + CBD + CBG combined was more effective than these compounds applied alone.”

Taking Rapid Relief Cooling Gel for a spin

The Rapid Relief Cooling Gel could not have arrived at a more opportune moment. I was looking at a triple threat of muscle soreness sources: it was the peak of 420 season—my busiest time of the work year, a funny consequence of working in cannabis, with many long hours hunched over the keyboard; I had just started jogging again, loving my daily run but feeling the consequences of using new muscles; and to top it all off, I was moving to a new house across town.

With a morning run and a long stretch spent stuck at a desk, and the rest of my hours taken up by lifting furniture, moving boxes, and pivoting down stairwells, I found muscles I didn’t even know I had yelling ‘uncle’ at this new routine. Lucky for me, I had a little relief waiting in the refrigerator.

I found muscles I didn’t even know I had yelling “uncle.” Lucky for me, I had a little relief waiting in the refrigerator.

No, not a cold beer—although I had those, too. Rare Cannabinoid Company recommends storing your Rapid Relief Cooling Gel in the refrigerator to enhance its cooling effect, an icy-hot tip that made applying the cream something to look forward to even for someone like me, who dreads applying sunscreen and face products since I tend to hate the feeling of lotion on my hands. With the gel, I could get an immediate sense of relief from the cooling sensation and light-mint, menthol-like scent, while it went on smooth and light on the skin, with a silky texture that absorbed completely within just a few minutes with no residue.

Post-workout application

I found that there were two key moments when the Rapid Relief Cooling Gel could best go to work whisking away my soreness and discomfort: one was directly post-workout when I could feel newly stretched muscles starting to tighten up. This was the perfect intervention moment before I sat down for my workday, whereas before, my muscles would go directly from getting their extra-exercise use to being stuck in one sitting position for long portions of the day. I found the cooling gel helped my muscles make the transition without getting inflamed and then locking into one spot for soreness to take root, instead feeling the rapid relief curb inflammation and help me stay loose through workday stress.

Before-bed application

I found the cooling gel helped my muscles make the transition without getting inflamed and then locking into one spot for soreness to take root, instead feeling the rapid relief curb inflammation and help me stay loose through workday stress.

The other moment that became a daily routine was to apply the Rapid Relief Cooling Gel just before going to bed. You know the feeling when you’re lying in bed about to go to sleep, and you just know you’re going to be sore in the morning? After hoisting load after load of books, records, and furniture of all shapes & sizes in and out of my car and over to our new place, I knew I was going to feel it the next day, and still have to do it all over again.

Applying the Rapid Relief Cooling Gel to my lower back during my nighttime routine, I let the lotion do its work while I recovered overnight and woke with my muscles feeling refreshed. Rather than having soreness set in overnight, I felt like I was getting ahead of my body’s reaction to the more-than-typical use and avoiding the pain that would lead to increased tension.

Free samples for you

I love using the Rapid Relief Cooling Gel and feel thankful for its perfectly timed entrance into my daily routine. But the awesome thing is, you don’t have to take my word for it: Rare Cannabinoid Company is offering completely free samples of the Rapid Relief Cooling Gel, with free shipping included and no credit card information required.

You can get one 3ml sample packet of the relief gel for free by supplying your email & mailing address, and RCC is also including a free sample in every order. If you’re not already familiar with Rare Cannabinoid Company’s apothecary suite of hemp cannabinoid products, there are some great formulas you might consider combining with the Rapid Relief Cooling Gel.

Rapid Relief Cooling Gel
Courtesy of Rare Cannabinoid Company

Rare Cannabinoid Company offers CBG gummies, THC+CBG gummies, and CBG oil tinctures if you’re interested in further amplifying CBG’s influence on pain and inflammation. For help falling asleep and staying asleep, RCC recommends their products including rare cannabinoid CBN, available in tinctures or their extra-tasty, huckleberry-flavored CBN gummies for sleep. For those using the Rapid Relief Cooling Gel for exercise recovery, you may want to explore RCC’s THCV products, focused on boosting energy and suppressing appetite. The CBC+THC Mood Gummies are perfect if you’re looking to bring a happy, blissful feeling to your day.

Get one 3ml packet of Rapid Relief Cooling Gel completely free. Plus, save nearly 30% this month with RCC’s special introductory & subscription offers!

If you’re interested in the Rapid Relief Cooling Gel, but would prefer a product without any THC, you’re in luck. Rare Cannabinoid Company offers Hawaiian Choice CBD Topical Gel, a luxurious lotion infused with premium, broad-spectrum Hawaiian-grown cannabinoids—2000mg CBD and 400mg CBG—that has had all lab-detectable traces of THC removed. The CBD cream also contains the highest quality lemongrass and eucalyptus essential oils for a refreshing scent. Popular in Hawaii’s luxury resort spas, the Hawaiian Choice CBD Topical Gel is a premium experience you can enjoy at home.

Rare Cannabinoid Company’s products are thoughtfully created for specific effects and benefits. For example, their CBDV oil tincture is designed to promote sociability and memory while reducing irritability, and CBDV is even being trialed on adults and children with autism spectrum disorder. If you’re unsure of which cannabinoids and products suit your needs, RCC offers a quick and easy one-minute Cannabinoid Finder Quiz. In addition to recommendations tailored to your needs, you’ll also receive a coupon code for your choice of up to 10 free gummies ($25).

Related

Rare cannabinoid gummies get a buzzy upgrade, featuring new options with and without delta-9 THC

Ready for relief? 250ml bottles of CBG+CBD+THC Rapid Relief Cooling Gel are available now—get yours.


Availability subject to law.



Source link

American College of Physicians

Is CBN Right For You

Published

on

By


Sitting at the crossroads of THC and CBD – CBD helps with sleep and pain. Could it be right for you?

Marijuana is been proven a benefit to the medical world and the American Medical Association, Health and Human Services, the American College of Physicians and the Food and Drug administration all support increasing it’s reach and for more research.  It has been shown to be particularly helpful with chronic pain, nausea, and sleep. The cannabis plant provide a variety of cannabinols, including CBD, marijuana and CBN. But the medical question is CBN right for you? It sits at the crossroads between CBD and THC can be useful with health issues.

RELATED: Science Says Medical Marijuana Improves Quality Of Life

Like CBD and THC, CBN is among the 100+ molecules in the cannabis plant. When THC is heated and exposed to CO2 (oxygen), it converts to CBN. The compound is said to have a mild psychoactive effect, slightly more so than CBD but much less than THC. Specifically, it is said to have a sedating effect on most users and to have promising sleep aid applications, similar to melatonin (among other potential uses).

How Marijuana's THCV Can Positively Impact Your Life
Photo by Bacsica/Getty Images

The marketing of CBN as a dietary supplement may be viable, provided that no unapproved health claims are made and could be nationally legal as long as they have a THC concentration of 0.3% or less. Unlike CBN and like THC, CBN is legal in some states, but not federally. The FDA likes to point out that the 2018 Farm Bill explicitly preserved FDA’s authority to regulate products containing cannabis or cannabis-derived compounds under the Food Drug & Cosmetic Act (“FDCA”) and section 351 of the Public Health Service Act. But the marketing of CBN as a dietary supplement may be viable nonetheless, provided that no unapproved health claims are made.

RELATED: What Is CBG And Is It Legal?

Unlike CBD, CBN not been approved as a drug, and FDA itself has acknowledged “parts of the cannabis plant that do not contain THC or CBD might fall outside the scope of the [drug exclusion rule].” As with CBG, if CBN is approved as a drug at some point down the line, it also seems likely that the drug exclusion rule would not apply: this is because the rule contains an exception for substances marketed as foods or dietary supplements prior to any FDA clinical investigation. People are already marketing CBN products as foods and dietary supplements.

Photo by Adrianna Calvo via Pexels

But the question is still, is CBN right for you? With regards to sleep, it is can be a bit stronger than CBD alone. While melatonin is a known as a good over the counter sleep aid, it doesn’t work for everyone.

A clinical study looked into sleep improvements from 15 mg of CBD with or without 15 mg of CBN compared with 5 mg of melatonin. In the study, all groups reported improved sleep quality, and there were no significant differences between products. Since this study didn’t look at CBN alone, it isn’t a direct comparison. But it seems to indicate that products containing an equal amount of CBD and CBN are similarly effective to melatonin for sleep. And adding a CBD/CBN product to melatonin didn’t provide any added benefit.

RELATED: Science Says Medical Marijuana Improves Quality Of Life

CBN use showed relief in muscle and joint pain conditions with inflammation. Limited studies show The study also noted that pain relief was better when CBD and CBN were used together.

So CBN can be helpful if you need a little extra in over the counter help.



Source link

Continue Reading

1:1

The best balanced CBD:THC weed seeds in 2024

Published

on

By


There should be no shame in any grower’s game if they ever age out of THC-dominant weed. Type 2 cannabis—meaning a strain that rocks equal or greater CBD-to-THC ratios—can be just as enjoyable and relieving as a heavy hitter, but on a different level. Cultivating Type 2 genetics from respected breeders can deliver a big yield and buds that are just as sticky and enjoyable as the intoxicating powerhouses we’re all used to.

Long-time home growers may finally be ready to hear what their mirthful medical bud-growing homies have been saying forever—the entourage effect is real, and it’s spectacular! Read on to discover it for yourself with the best balanced CBD:THC weed seeds and clones to grow in 2024!

What are Type 2 seeds?

A Type 2 cannabis seed typically distinguishes itself as having a balanced 1:1 ratio of THC and CBD. Other “mixed-ratio” seeds with a CBD-dominant ratio like 2:1 or 5:2 are often considered Type 2 as well. As several breeders confirmed to me, these ratios can also include a variety of minor cannabinoids in similar ratios.

In comparison, Type 1 seeds are THC-dominant (more than 0.3%) with a very low amount of CBD (less than 0.5%). 

Type 3 seeds, on the other hand, are even more CBD-dominant; they have ratios like 20:1, and offer barely any psychoactive effect.

Why should home growers choose Type 2 seeds?

To get the scoop on what’s up with going Type 2, I went coast-to-coast to learn from two “Pauls” who are both big-time seed guys: Paul N. Chucker of D.C. Seed Exchange and Paul Lawl of Multiverse Beans in Washington State. 

“Some of my best highs have come from hemp flower. People who don’t try ratio strains are really missing out,” Lawl mentioned. “In my experience, the CBD really helps cancel out the anxiety from the high THC strains,” he added.

Paul Chucker, of DCSE, explained that he sees “a lack of awareness about the benefits of diverse cannabinoids and the entourage effect,” and pointed out that the entourage effect “enhances their benefits, potentially leading to more well-rounded experiences and addressing a wider range of needs.” 

green and purple bud closeup
These cicadas are buzzzzzing. Crickets and Cicadas’ Panama Red CBD

Some top-notch 1:1 Type 2 seeds to try

Breeders like Rab Stubing, founder of Seattle Chronic Seeds, drop strains with therapeutic and often-manageable balanced ratios. Stubing has made it his mission to fill a void with various ratios and cannabinoids in his seed varieties. 

Shop highly rated dispensaries near you

Showing you dispensaries near

See all dispensaries

Looking for somewhere to start your Type 2 journey? Check out Miracle Worker, one of Stubing’s favorite 1:1 strains. 

Super Sour CBD, another fave, features the highest levels of 1:1 CBD in any of his Type 2 work. A cross of Sour Brasi x Sour D BX/OX x Sour CBD Grenades, this super stable F8 is available as regular seeds and boasts levels in the 12% CBD/12% THC ballpark. Those levels make it a great medical smoke. Earthy and super sour, it’s known to be a wonder for a wide range of pain, mobility, and mood issues. 

Here are some more great seed choices:

  • JD Short’s Second Generation Genetics is rocking a stellar Rosaberry F1
  • If you’re in California, check out Purple City Genetics’ Gush Mints CBD (Gush Mints x Fruitcake) feminized seeds. This Cali exclusive has some phenos that top out at 20% CBD/20% THC along with a sensational frosty purple bag appeal! Check out this list of shops that carry PCG’s top-quality Type 2’s

1:1 Type 2 Autoflower seeds

Autoflower seed breeders have not slouched when it comes to excellent cultivars that provide balanced medicinal value. 

Mephisto Genetics released Aunt Ginny’s Elixir (Jacky CBD F3.3 x Walter White (Mitch’s Pick) in their feminized Medicinal Collection. It joins their Canna-Cheese 1:1 (Cannatonic x Northern Cheese Haze) available at F5 which, according to Mephisto co-founder and breeder Tim, is “their greatest achievement.” 

“Getting CBD into something where it wasn’t before was very difficult, and was quite a fun journey with Canna-Cheese,” he fondly reflected when we spoke back in 2023. 

Looking for more Type 2 autoflower reccs? Check out the Seattle Chronic gem Speedy SOGA F3 (SOGAbx2 x R4 Auto), Twenty20 Mendocino’s VitaMints, and Dutch Passion’s Compassion Lime Auto & Blackberry Kush Auto fems.

Related

Leafly’s top CBD strains—Summer 2023

1:1 Type 2 hemp seed genetics

Thanks to the 2018 Farm Bill, hemp breeders can take their federally-compliant genetics game to the next level—Type 2—because the law permits seeds containing up to 0.3% THC. Phenotypes can be selected for Farm Bill compliance, and they’re just as dank, beautiful, and therapeutic as anything else on the market.

Hoku Seed Co.

The breeder Floyd, of Hoku Seed Co. was already a medical grower when he started his popular seed company in 2019, after the Farm Bill went into law. Since then he’s been on a tear to develop various types of seeds including regular and feminized Type 2 seeds with a wide range of cannabinoids. 

Cultivars are available for both Farm Bill compliance ( <0.3 THC) for hemp growers, and for home growers that wish to go beyond hemp with higher THC levels countered by even higher CBD levels. 

“Now we’re also even getting into even more chemotypes,” Floyd explained during a very informative chat in early January. “We’re working on Type 2’s but they’re also CBD-V and THC-V-rich. They have four different cannabinoids. Some of the variants are very uplifting.” 

Some of Floyd’s picks include: 

High Alpine Genetics

plant growing in indoor grow
Behold, High Alpine’s Unicorn Butter.

Atop any list of the finest CBD-rich genetics stands High Alpine Genetics and the company’s founder/breeder Thomas. As a committee member of the Hemp Advisory Board for the State of Colorado, he knows a thing or two about this stuff. His cultivars feature open-source genetics that he encourages and and everyone to breed with and clone to their hearts’ content.

“Our varieties tend to have a more broad spectrum of cannabinoids in them,” he explained during a quick chat from his farm. “CBC, CBG, CBD-V—a lot of them carry different cannabinoids that you really don’t see with just THC.”

Broad spectrum High Alpine Genetics Type 2 seeds for any home grow set-up include the CBC-heavy Unicorn Butter, and its parents Buddha’s Budda and Unicorn Crush

F1 crosses now available also include Limburger Burger (Lemon Cookie Dough Limburger Phenotype), Cookie Burgers, and the Legendary Banana Mac-cross, Alien Burgers. Fries not included.

Mixed cannabinoid ratios

The breeders I spoke to generally agree that Type 2 seeds can include mixed ratios and various cannabinoids, including CBD-V, THC-V, CBG, and CBC, to name a few. “A lot of people think that Type 2 can only be a 1:1, but I don’t think that’s necessarily true,” Floyd, of Hoku, told me.

With that in mind, here’s a roundup of some of the funkiest ratios on the market.

  • Hoku’s Wild Country is an 8:1 CBD-dominant hash plant.
  • Check out Humboldt’s CBD Trifecta, an all-in-one pack of High CBD, low-THC strains x 3 (Honey-Tsu, Love, Lucy, Harle-Spice).
  • Crickets and Cicadas’ Panama Red F4 regular seeds are 2:1.
  • Cali Connection’s CBD OGfeatures a 2:1 ratio.
  • Interested in seeds that contain even more CBD with Type 3 and other cannabinoids? Check out Hoku Seed Co. & High Alpine Genetics’ endless high-quality choices.
vape cart package against white background
Humboldt Seed Co.’s CBD Trifecta vape cart.

Select the right Type 2 profiles and ratios 

Type 2 cannabis seeds have a high return value due to their potential to take the edge off of pain and anxiety, courtesy of their differing blends of cannabinoids. They can also help consumers have more control over the experience, instead of always letting the high-potency weed run the show. 

Select from a wide variety of versatile seeds for your relaxation needs. No matter whether it’s Type 2 1:1’s, mixed ratios, or even Type 3 or 4 genetics, it’s time to graduate to the next level. 





Source link

Continue Reading

2023 U.S. National Cannabinoid Report

Cannabinoids Bring in More Than Legal Markets

Published

on

By


A new report by Whitney Economics highlights how the illegal cannabinoids industry, brings in more money than legal weed markets.

New report by Whitney Economics

The cannabinoids market came into being following the 2018 US Farm Bill, which legalized industrial hemp cultivation and production. It didn’t legalize the use of products for any kind of nutritional supplementation or food, or permit synthetic processing. Though federal congress has proposed laws for the former, nothing has gone through, and the FDA claims it cannot update this on its own. As such, its legal to produce hemp; but all hemp-derived cannabinoids (products that use hemp as a base material) are unregulated for internal use, and not part of legal markets.

Whitney Economics is a data  and consulting operation in the weed and hemp space, which is based out of Portland, Oregon. It works with both government agencies and private enterprises, at both the state and federal levels; to help create workable economic strategies and policy, for related businesses and projects.

Earlier this year, Whitney made clear for the public, just how much the federal government takes indirectly in cannabis taxes, via Section 280E of the federal tax code. At that time, the company estimated that cannabis businesses had overpaid $1.8 billion in 2022 alone; with an expected increase to $2.1 billion for 2023. The company also said that in a survey of businesses from 2022, that only 24.4% of legal operators made a profit that year. Now, Whitney has some new news, and it might not be what regulators really want to hear.

cannabinoids can be directly extracted or hemp-derived
cannabinoids can be directly extracted or hemp-derived

According to Whitney’s 2023 U.S. National Cannabinoid Report, which analyzed the impact of the hemp-derived cannabinoids industry on legal markets; hemp-derived weed sales outpaced every legal state market, in 2022. The report put sales for cannabinoids at about the level of craft beer sales in the country.

How much revenue did the cannabinoids market make, in 2022? Whitney estimates that CBD and other cannabinoids like delta-8 THC, brought in around $28.4 billion. Per the report, “For context, hemp-derived cannabinoid sales nationally were greater than total legal sales of medical and adult-use cannabis in 2022.”

It continues, “Currently, the total demand for hemp-derived cannabinoids is valued in excess of $28 billion and supports the employment of 328,000 workers, who earn $13 billion in wages. Overall, the total economic impact of the hemp-derived cannabinoid industry on the U.S. economy is in excess of $79 billion.” It also said that “While they may seem large, these estimates are actually conservative, because they do not account for demand and employment from gas stations, grocery stores and convenience stores.”

Why are we only hearing this now?

The report didn’t make a big deal about the term ‘black market,’ referring to it instead as ‘illicit.’ But the terms mean the same thing. The hemp-derived cannabinoids market is a black market, and no products in it are approved. While some products collect sales tax for governments, others are not scanned at all, or only for show. This means, no government has direct statistics of how large this (or any) black market is.

It’s not that we’re not being told the sales comparison, its because there isn’t one in hard numbers. And the unfortunate truth of gray areas in information, means that anything can be said. Think of all those headlines about how much money cannabis taxes bring in. Well, those amounts are far less than expected and hoped for, regardless of their hype. And we know this because of the sheer size of the black market; which indicates only a percentage of people use legal dispensaries.

To give a quick example on this one, consider that New York has had an operational market for the better part of a year. Yet it was reported in the spring (and then repeated in September) that the state only gave out about 60 licenses for legal establishments. And this while approximately 1,400 illicit stores exist. Just taking those numbers into account, (which is conservative given that the 60 licenses might not all be operational dispensaries yet); it becomes clear that the black market is way bigger, and therefore likely makes way more money.

Since governments don’t technically tax black markets, all we have are estimates. It should be noted that sales tax is applied to some products; but sin (excise) taxes uniformly are not, nor are THC taxes, cultivation taxes, or any other industry-specific taxes. Beyond this, no sales information is collected on most of these purchases.

The weed black market isn’t that different from the growing vape market; most of which functions outside of regulation. This applies to both disposable vapes, as well as other non-disposable products. While we once gain don’t have direct numbers to compare sales, we can consider the following: Grand View Research estimated just the disposable market brought in close to $6 billion in 2021, with an expected yearly growth rate of over 11% until 2030.

It was also estimated that 9,000+ vape products are on the market in the US, and nearly 40% are disposables. As no disposables are legal, this indicates automatically at least 40% of the market is illegal. Seeing as how governments apparently approved less than 1% of vape product applications, the illicit number could be closer to 90%+. We’re never told about this in terms of a lack of government revenue; instead, the public hears about it as fear campaigns meant to dissuade it from buying certain products.

What Whitney report tells us about cannabinoids and legal markets?

The report helps put into perspective, the actual situation at hand. It pops the balloon of reporting that seeks to claim the legal markets are sky-rocketing in success. Realistically, we know this can’t be true due to all the issues with broke cultivators, overproduction, layoffs, and lowered product prices despite high taxes and regulatory fees. We can know it logically by these discrepancies; but a report like this shines a light on the issue.

The report makes clear that lawmakers should consider the size of this hemp-derived market when making regulatory decisions. Report author Beau Whitney explained to Marijuana Moment that legal market regulators “do not have the data on how large the market is and the large number of consumers that prefer this over adult-use and medical. The result is large labor displacement and increased business failures.”

Whitney continued that regulators should look to embrace this market, rather than try to destroy it, saying “It was unfortunate that ‘big cannabis’ is villainizing the hemp industry, when they are making hundreds of million of dollars in revenue from the sale of these very same hemp-derived products.”

He goes on that “We at Whitney Economics feel that the adult-use and medical markets should support the hemp distribution model as it allows for widespread distribution for cannabinoids. If adult-use and medical would follow this path, there would be massive opportunities for growers, processors and manufacturers and would make a significant dent into illicit sales (through greater access and greater legal consumer participation).”

As in, if the legal markets really want to fight the black market, and divert more sales to legal vendors; they must be competitive with it. He’s saying, the popularity of hemp-derived products shouldn’t be ignored, as this can inform future sales. According to the report’s Executive Summary:

“Federal regulation was not able to keep pace with the rapid deployment of hemp products on the market. While mostly self-regulated (with the exception of the cultivation of hemp), concerns arose over the potential intoxicating effect of some cannabinoid products, and the potential public safety risks associated with intoxication. State legislatures attempted to intervene and provide regulatory structure to the industry, but those efforts have generated several unintended consequences on the industry.”

It then explains, “In order to address these issues, policy makers at all levels require data. Up to this point, there has not been a comprehensive, national assessment of the hemp-derived cannabinoid industry. Whitney Economics has taken a conservative approach to data gathering and projections. The intention of this report is to provide a baseline of data in order to help hemp industry stakeholders understand the level of economic activity associated with hemp cannabinoids, and the impact that policy changes will have on the future.”

Conclusion

Weed black markets – including the cannabinoids industry, are a huge source of competition for legal markets. I expect these figures relate to black market sales in general, and include non-hemp-derived products sold by black market pharmacies; although I cannot confirm this. It shouldn’t be shocking that governments will likely ignore all of it, though. Let’s be honest, they already know the situation; and that hasn’t led to legislation that makes sense. Given this repeated history across states, it’s genuinely hard to believe this report will change anything.

Thanks for joining us today. Welcome to Cannadelics.com; an independent rag, covering the drugs world at large, with a focus on cannabis and hallucinogens. We’re here everyday, so come by frequently to visit; and head over to the Cannadelics Weekly Newsletter; for the best product offers in conjunction with the news.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media